This topic contains a solution. Click here to go to the answer

Author Question: A nonmodifiable risk factor for the development of cataracts is A. Long-term exposure to ... (Read 103 times)

daltonest1984

  • Hero Member
  • *****
  • Posts: 536
A nonmodifiable risk factor for the development of cataracts is
 
  A. Long-term exposure to ultraviolet B radiation
  B. High alcohol intake
  C. Strong family history
  D. Diabetes mellitus

Question 2

Sensory impairment (vision and hearing) in the elderly is associated with
 
  A. Impaired quality of life
  B. Decreased function
  C. Increased mortality
  D. All of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

alvinum

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

C

Answer to Question 2

D




daltonest1984

  • Member
  • Posts: 536
Reply 2 on: Jul 11, 2018
Thanks for the timely response, appreciate it


shailee

  • Member
  • Posts: 392
Reply 3 on: Yesterday
Gracias!

 

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library